Popular Cirrhosis News and Current Events

Popular Cirrhosis News and Current Events, Cirrhosis News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 19 | 726 Results
Mediterranean-style diet improves gut microbial diversity and reduces hospitalization
ILC 2018: Diets rich in vegetables, fermented milk products, tea, coffee and chocolate may improve outcomes in patients with liver cirrhosis. (2018-04-12)

Selective internal radiation therapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort
ILC 2018: The addition of SIRT to sorafenib in patients with advanced hepatocellular carcinoma was associated with no overall survival benefits compared with sorafenib alone, but may offer benefits in some subgroups of patients (2018-04-13)

Researchers find a promising new approach for treating liver cirrhosis
In a study in The American Journal of Pathology, investigators report that treatment with aleglitazar, a dual peroxisome proliferator-activated receptor-alpha/gamma (PPARα/γ) agonist, reduced inflammation, vasoconstriction, angiogenesis, mucosal disruption, and tumor necrosis factor (TNF)-α overproduction in cirrhotic rats with PH. This suggests a promising new approach for treating liver cirrhosis. (2018-06-18)

How to select anti-hepatitis B virus agents for drug-resistance patients?
Chronic hepatitis B virus (HBV) infection remains a global public health problem. Nucleoside analogs play an important role in antiviral therapy for chronic hepatitis B patients. However, many patients with a certain nucleoside analogs therapy for a period of time may be resistant to this antiviral agent. This article described a useful strategy to select anti-HBV agents for drug-resistance patients. (2008-09-24)

Screening for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis achieving sustained virological response is likely to be cost effective
A Canadian study suggests that biannual or annual ultrasound screening for HCC is likely to be cost effective after a sustained virological response in those with hepatitis C-related cirrhosis, but not in those with advanced fibrosis without cirrhosis. (2018-04-12)

Vitamin D deficiency common in patients with IBD, chronic liver disease
The 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found patients with inflammatory bowel disease or chronic liver disease were at increased risk of developing Vitamin D deficiencies. Two separate studies highlight the importance of regular Vitamin D checkups in the evaluation of patients with certain digestive diseases. (2008-10-06)

Clues to the link between obesity and liver cancer-and identification of a new risk group
New research has found a previously overlooked group of obese people may be at risk of developing deadly liver cancer. Most obese individuals who develop liver cancer first develop non-alcoholic fatty liver disease, and then the more severe non-alcoholic steatohepatitis. This can lead to cirrhosis and liver failure. However, this research reveals pathways to the development of liver cancer in obese people that are not reliant on the development of non-alcoholic steatohepatitis or cirrhosis. (2018-10-25)

Budesonide add-on therapy improves markers of disease activity but fails to improve histology in patients with primary biliary cholangitis
A randomized, placebo-controlled study reports that budesonide add-on therapy improves biochemical markers of disease activity but not histology in high-risk patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid. (2018-04-13)

Fecal microbiota transplantation produces sustained improvements in cognitive and clinical outcomes
Long-term results of a randomized study demonstrate sustained improvements in hepatic encephalopathy episodes, hospitalizations, and cognitive performance compared with standard-of-care. (2018-04-14)

Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races. The study also suggests that although other factors such as liver cancer or hepatitis may negatively influence long-term survival, race does not. (2008-05-19)

Germany: compensated cirrhosis substantially increases comorbidities and healthcare costs for patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
Compensated cirrhosis substantially increases comorbidities and healthcare costs for patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. (2018-04-13)

Alcohol related deaths are likely to increase after cuts in alcohol taxation
Alcohol related deaths are most likely set to increase in England as incomes outstrip rises in taxation, argue experts in The BMJ today. (2016-04-06)

New affordable hepatitis C combination treatment shows 97 percent cure rate
The sofosbuvir/ravidasvir combination treatment for hepatitis C has been shown to be safe and effective, with extremely high cure rates, according to interim results from the Phase II/III STORM-C-1 trial presented by DNDi at the International Liver Conference in Paris. (2018-04-12)

The risk factors of idiopathic pulmonary fibrosis in HCV patients
A group from Toranomon Hospital of Japan investigated the cumulative development incidence and predictive factors for idiopathic pulmonary fibrosis in HCV positive patients. They found that age, smoking and liver cirrhosis enhance the development of idiopathic pulmonary fibrosis in HCV positive patients. (2008-10-23)

Sustained virological response to oral hepatitis C virus treatment associated with reduced mortality in an Italian cohort
A large-scale, real-world data on the course of liver disease after clearance of HCV with direct-acting antiviral agents show reduced risk of death at all stages of disease. (2018-04-13)

Gut microbes could help better predict risk of hospitalization for patients with cirrhosis
The gut microbiome -- a collection of bacteria and other microbes in the gut -- could be a highly accurate predictor of hospitalizations for patients with cirrhosis, according to a recently published study led by a researcher at Virginia Commonwealth University. (2018-03-30)

Long-term obeticholic acid treatment leads to reversal or stabilization of fibrosis/cirrhosis in patients with PBC
After three years of treatment with obeticholic acid, 85 percent of patients with PBC and an incomplete response to UDCA experienced stabilization or regression of fibrosis/cirrhosis in the POISE biopsy sub-study. (2018-04-13)

Insurance denials for new hepatitis C drugs remain high nationwide, study suggests
Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the US in 2014. But both public and private insurers continue to deny coverage for these costly drugs at high rates nationwide, despite efforts to remove treatment restrictions, according to a new study published in Open Forum Infectious Diseases. (2018-06-07)

New test allows for one-step diagnosis of HCV infection
The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. Now researchers have developed a novel enzyme immunoassay that accomplishes screening and diagnosis in one simple and affordable step. (2016-06-07)

Hepatocellular carcinoma: Resection vs. transplantation
Liver transplantation is the gold standard for treating early hepatocellular cancers. Because of the lack of donors, this option is, however, available to a limited degree only. Curative liver resection is an alternative in this setting. Markus B. Schoenberg, Julian N. Bucher, and coauthors investigated whether liver resection can yield results that are comparable to those of liver transplantation. (2017-09-08)

Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure
A program of decentralized public healthcare achieves high rates of cure regardless of genotype or the presence of cirrhosis: the Punjab Model. (2018-04-12)

Alcohol consumption in late teens can lead to liver problems in adulthood
Alcohol is the leading cause of liver cirrhosis and liver-related deaths. Results of a large long-term study in Sweden have confirmed that drinking during late adolescence could be the first step towards liver problems in adulthood and that guidelines for safe alcohol intake in men might have to be revised downwards, reports the Journal of Hepatology. (2018-01-21)

A third of bacterial infections in patients with cirrhosis across the world are multi-drug resistant
An international study reports a high prevalence of multi-drug-resistant bacteria in hospitalized patients with cirrhosis and significant regional differences in risk. (2018-04-12)

Gold standard monitoring of HCC in patients with cirrhosis is cost-effective
Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. A new analysis indicates that following screening guidelines for HCC in cirrhotic patients is lifesaving and cost-effective compared with 'real life' monitoring. (2017-02-08)

New leads in the development and treatment of liver disease
A treatment gap remains for many conditions involving damage to the liver, the body's main organ for removing toxins, among other functions. The Experimental Biology 2018 meeting (EB 2018) will feature important research announcements related to the causes of liver degradation and possible treatments. (2018-04-21)

A South American amphibian could potentially hold the key in curing cirrhosis
The unique liver function of a South American amphibian, Siphonops annulatus, could pave the way to finding a cure to the devastating liver condition cirrhosis, a new study published in the prestigious Journal of Anatomy reports. (2017-12-06)

Cultural values can be a strong predictor of alcohol consumption
New research shows that countries with populations that value autonomy and harmony tend to have higher average levels of alcohol consumption than countries with more traditional values, such as hierarchy and being part of a collective. The findings have implications for tackling problems associated with alcohol consumption. (2017-11-20)

Portal vein thrombosis is common in extraportal vein obstruction
The etiology and pathogenesis of portal vein thrombosis is unclear. A two-year study led by Dr. Pankaj Jain and Dr. Sandeep Nijhawan from Sawai Man Singh Hospital investigated 118 patients with portal vein thrombosis. Among the 118 patients with portal vein thrombosis, 42.4 percent had liver malignancy (primary or metastatic), 15.3 percent had cirrhosis, 6 percent pancreatitis (acute or chronic), 5 percent had hypercoagulable state and 31.3 percent were idiopathic. (2007-10-12)

First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
Studies conducted in Italy and Germany confirm the effectiveness and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection, with viral suppression rates similar to those observed in clinical trials. (2018-04-12)

Fatty liver under stress
A poor diet and other risk factors can result in liver disease. This important metabolic organ can become fatty and inflamed. In the long term, this may result in irreversible and life-threatening organ damage (cirrhosis of the liver or 'shrunken liver'). Experts at the German Federal Institute for Risk Assessment (BfR) in Berlin have now analyzed liver cells in vitro to investigate how degenerative fattening and inflammation can impair the body's primary detoxification system. (2018-04-09)

Cancer stem cells, allies of the tumor and enemies of the patient
Research results point to a therapeutic value for the protein (Ahr) because controlling it might repress the pluripotency of the cancer stem cell and reduce the malignity of the tumour. Indeed, different naturally-occurring molecules have been identified that modulate the activity of this protein in specific ways. In addition, the dioxin receptor might also facilitate the development of tools for the prognosis and evolution of the types of cancer in the study, hepatocellular carcinoma and melanoma. (2018-03-05)

Study finds high health burdens of very high risk drinking
In an Addiction Biology study, the estimated prevalence of very high risk drinking level (VHRDL, defined as drinking >100 g of ethanol per day) in 13 European Union countries was 0.74-0.85 percent, with a risk of disease or injury of 13.5 per 100 people with VHRDL per year. (2018-07-18)

WHO guidelines fail to detect half of chronic hepatitis B patients in Ethiopia needing treatment
Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier. They propose revision of the guidelines to consider local data from sub-Saharan Africa in order to help reach the WHO goal of eliminating viral hepatitis as a major public health threat by 2030. (2019-03-28)

Latest findings on how alcohol impairs the immune system
On Nov. 22, leading alcohol researchers from the United States and Europe will present the latest findings on how alcohol impairs the immune system. The all-day conference will be held on the Loyola University Chicago Health Sciences Campus in Maywood, Ill. (2013-11-20)

Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage
Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency. Scientists at Cold Spring Harbor Laboratory today reported that a particular class of senescent liver cells orchestrates a sequence of events in living mice that can limit fibrosis, a natural response of the liver to acute damage. (2008-08-21)

Liver cancer caused by alcohol consumption may have worse prognosis than other forms
A new study indicates that patients with alcohol-related liver cancer often do not live as long as patients with liver cancer that is not associated with alcohol consumption, mainly due to diagnoses at later stages. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that efforts should be made to improve both screening for early signs of liver cancer and the management of alcohol abuse. (2018-03-28)

New radiological procedure for the diagnosis of liver disease
Researchers from Charité -- Universitätsmedizin Berlin have successfully tested a new technology for use in the assessment of overweight adolescents with liver disease. Known as 'time-harmonic elastography' (THE), the technology enables physicians to determine the disease's severity without having to resort to invasive liver biopsies. The results of this research have been published in Radiology*. (2018-06-18)

Surrey develops hepatitis C model that could help improve treatment
The University of Surrey has created a new mathematical model that details how the hepatitis C (HCV) infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment for the infection that affects 215,000 people in the United Kingdom. (2018-05-29)

New treatment algorithm can predict benefit of treatment in end-stage liver disease
A new algorithm designed to help physician decision-making in End-Stage Liver Disease (ESLD), was able to accurately predict death in 96 percent of patients with ESLD. (2016-04-15)

The Lancet: Major progress against hepatitis C by 2030 is possible, but will need vast improvements in screening, prevention and treatment
A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally published in The Lancet. (2019-01-28)

Page 1 of 19 | 726 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.